Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127625251 | 12762525 | 1 | I | 20140905 | 20160913 | 20160920 | 20160920 | EXP | GB-MHRA-EYC 00145023 | GB-PFIZER INC-2016431346 | PFIZER | 55.00 | YR | M | Y | 0.00000 | 20160920 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127625251 | 12762525 | 1 | PS | FENTANYL. | FENTANYL | 1 | Parenteral | 100 UG, UNK | D | HAMELN PHARMACEUTICALS | 19115 | 100 | UG | ||||||
| 127625251 | 12762525 | 2 | SS | CHIROCAINE | LEVOBUPIVACAINE HYDROCHLORIDE | 1 | Parenteral | 13 ML, UNK | D | ABBOTT | 0 | 13 | ML | ||||||
| 127625251 | 12762525 | 3 | SS | LIDOCAINE. | LIDOCAINE | 1 | Parenteral | 30 MG, UNK | D | B BRAUN | 0 | 30 | MG | ||||||
| 127625251 | 12762525 | 4 | SS | MIDAZOLAM | MIDAZOLAMMIDAZOLAM HYDROCHLORIDE | 1 | Parenteral | 5 MG, UNK | D | MERCURY PHARMA | 0 | 5 | MG | ||||||
| 127625251 | 12762525 | 5 | SS | NORMAL SALINE | SODIUM CHLORIDE | 1 | Parenteral | 5 MG, UNK | D | FENNING | 0 | 5 | MG | ||||||
| 127625251 | 12762525 | 6 | SS | NORMAL SALINE | SODIUM CHLORIDE | 1 | Parenteral | UNK | D | 0 | |||||||||
| 127625251 | 12762525 | 7 | SS | TRIAMCINOLONE | TRIAMCINOLONE | 1 | Parenteral | 86 MG, UNK | D | SQUIBB | 0 | 86 | MG | ||||||
| 127625251 | 12762525 | 8 | C | CLONAZEPAM. | CLONAZEPAM | 1 | 2 MG, 2X/DAY | 0 | 2 | MG | BID | ||||||||
| 127625251 | 12762525 | 9 | C | EPILIM | VALPROATE SODIUM | 1 | 100 MG, 1X/DAY | 0 | 100 | MG | QD | ||||||||
| 127625251 | 12762525 | 10 | C | GABAPENTIN. | GABAPENTIN | 1 | PLUS EXTRA DOSE AT NIGHT. | 0 | 400 | MG | |||||||||
| 127625251 | 12762525 | 11 | C | GLUCOSAMINE SULPHATE | GLUCOSAMINE | 1 | 2 DF, 1X/DAY | 0 | 2 | DF | QD | ||||||||
| 127625251 | 12762525 | 12 | C | MORPHINE SULFATE. | MORPHINE SULFATE | 1 | 10MG/5ML | 0 | |||||||||||
| 127625251 | 12762525 | 13 | C | RANITIDINE. | RANITIDINE | 1 | 1-2 ONCE DAILY | 0 | |||||||||||
| 127625251 | 12762525 | 14 | C | TRAMADOL. | TRAMADOL | 1 | ONE OR TWO 4 TIMES DAILY. | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127625251 | 12762525 | 1 | Sedation |
| 127625251 | 12762525 | 2 | Sedation |
| 127625251 | 12762525 | 3 | Sedation |
| 127625251 | 12762525 | 4 | Sedation |
| 127625251 | 12762525 | 5 | Sedation |
| 127625251 | 12762525 | 7 | Sedation |
| 127625251 | 12762525 | 12 | Breakthrough pain |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127625251 | 12762525 | DS |
| 127625251 | 12762525 | HO |
| 127625251 | 12762525 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127625251 | 12762525 | Ageusia | |
| 127625251 | 12762525 | Amnesia | |
| 127625251 | 12762525 | Circulatory collapse | |
| 127625251 | 12762525 | Decreased appetite | |
| 127625251 | 12762525 | Discomfort | |
| 127625251 | 12762525 | Dissociative amnesia | |
| 127625251 | 12762525 | Dysgeusia | |
| 127625251 | 12762525 | Dysgraphia | |
| 127625251 | 12762525 | Erythema | |
| 127625251 | 12762525 | Eye pain | |
| 127625251 | 12762525 | Facial paralysis | |
| 127625251 | 12762525 | Hallucination | |
| 127625251 | 12762525 | Headache | |
| 127625251 | 12762525 | Hemiparesis | |
| 127625251 | 12762525 | Hypoaesthesia oral | |
| 127625251 | 12762525 | Loss of consciousness | |
| 127625251 | 12762525 | Muscle spasms | |
| 127625251 | 12762525 | Muscle twitching | |
| 127625251 | 12762525 | Muscular weakness | |
| 127625251 | 12762525 | Musculoskeletal stiffness | |
| 127625251 | 12762525 | Mydriasis | |
| 127625251 | 12762525 | Nausea | |
| 127625251 | 12762525 | Nightmare | |
| 127625251 | 12762525 | Ocular hyperaemia | |
| 127625251 | 12762525 | Pain | |
| 127625251 | 12762525 | Photosensitivity reaction | |
| 127625251 | 12762525 | Rash | |
| 127625251 | 12762525 | Skin warm | |
| 127625251 | 12762525 | Speech disorder | |
| 127625251 | 12762525 | Unresponsive to stimuli |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127625251 | 12762525 | 1 | 20140904 | 20140904 | 0 | |
| 127625251 | 12762525 | 2 | 20140904 | 20140904 | 0 | |
| 127625251 | 12762525 | 3 | 20140904 | 20140904 | 0 | |
| 127625251 | 12762525 | 4 | 20140904 | 20140904 | 0 | |
| 127625251 | 12762525 | 5 | 20140904 | 20140904 | 0 | |
| 127625251 | 12762525 | 6 | 20140904 | 20140904 | 0 | |
| 127625251 | 12762525 | 7 | 20140904 | 20140904 | 0 |